Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis

Lancet

Volumn 357, Issue 9266, 2001, Pages 1397-1401

  Kral, Alex H ^a,c   Bluthenthal, Ricky N ^d   Lorvick, Jennifer ^a   Gee, Lauren ^a   Bacchetti, Peter ^b   Edlin, Brian R ^a  

^a Inst Hlth Plcy Studs Depts F   (United States)

^b Epidemiology and Biostatistics and Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INJECTION; MALE; PRIORITY JOURNAL; PROSTITUTION; RISK FACTOR; SEROCONVERSION; SEXUAL TRANSMISSION; UNITED STATES;

EID: 0035810605     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04562-1     Document Type: Article

References (40)

1. Holmberg S.D. The estimated prevalence and incidence of HIV in 96 large USmetropolitan areas. Am J Public Health. 86:1996;6442-6654.
2. van Ameijden E.J., van den Hoek J.A., van Haastrecht H.J., Coutinho R.A. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. Am J Epidemiol. 136:1992;236-243.
3. Nicolosi A., Musicco M., Saracco A., Molinari S., Ziliani N., Lazzarin A. Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and northern Italy, 1987-1989. Epidemiology. 1:1990;453-459.
4. Friedman S.R., Jose B., Deren S., Des Jarlais D.C., Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol. 142:1995;864-874.
5. Moss A.R., Vranizan K., Gorter R., Bacchetti P., Watters J., Osmond D. HIV seroconversion in intravenous drug users in San Francisco, 1985-90. AIDS. 8:1994;223-231.
6. Solomon L., Astemborski J., Warren D., et al. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. Am J Epidemiol. 137:1993;892-898.
7. Rhodes T., Stimson G.V., Crofts N., Ball A., Dehne K., Khodakevich L. Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. AIDS. 13:(suppl A):1999;259-269.
8. Kral A.H., Bluthenthal R.N., Booth R.E., Watters J.K. HIVseroprevalence among street-recruited injecting drug and crack cocaine users in 16 US municipalities. Am J Public Health. 88:1998;108-113.
9. Watters J.K. Trends in risk behaviors and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992. J Acquir Immune Defic Syndr Hum Retrovirol. 7:1994;1276-1281.
10. Kral A.H., Bluthenthal R.N., Erringer E.A., Lorvick J., Edlin B.R. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 94:1999;675-683.
11. San Francisco Department of Public Health. HIV prevalence and incidence in San Francisco. San Francisco: HIV Seroepidemiology Unit, San Francisco Department of Public Health, 1997.
12. Fisher D.G., Fenaughty A.M., Trubatch B. Seroconversion issues among out-of-treatment injection drug users. J Psychoactive Drugs. 30:1998;299-305.
13. Kellogg T., McFarland W., Katz M. Recent increases in HIVseroconversion among repeat anonymous testers in San Francisco. AIDS. 13:1999;2303-2304.
14. McFarland W., Kellog T.A., Dilley J., Katz M.H. Estimation of human immunodeficiency virus (HIV) seroincidence among repeat anonymous testers in San Francisco. Am J Epidemiol. 146:1997;662-664.
15. DesJarlais D.C. Harm reduction:a framework for incorporating science into drug policy. Am J Public Health. 85:1995;10-12.
16. Bluthenthal R.N., Kral A.H., Erringer E.A., Edlin B.R. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992-1995. J Acquir Immune Defic Syndr Hum Retrovirol. 18:1992;505-511.
17. Watters J.K., Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Problems. 36:1989;416-430.
18. Centers for Disease Control and Prevention. Interpretive criteria used to report western blot results for HIV-1-antibody testing - United States. MMWR Morb Mortal Wkly Rep 1991; 40: 692-95.
19. Strathdee S.A., Galai N., Safaiean M., et al. Gender differences in risk factors for HIV seroconversion among injection drug users: a ten year perspective. Arch Intern Med (in press).
20. Rhodes T., Stimson G.V., Quirk A. Sex, drugs, intervention, and research: from the individual to the social. Subst Use Misuse. 31:1996;375-407.
21. Calsyn D.A., Saxon A.J., Wells E.A., Greenberg D.M. Longitudinal sexual behavior changes in injecting drug users. AIDS. 6:1992;1207-1211.
22. Latkin C.A. Outreach in natural settings: the use of peer leaders for HIVprevention among injecting drug users' networks. Public Health Rep. 113:(suppl):1998;151-159.
23. The CDC AIDS Community Demonstration Projects Research Group. Community-level HIVintervention in 5 cities: final outcome data from the CDC AIDScommunity demonstration projects. Am J Public Health 1999; 89: 336-45.
24. Downing M., Knight K.R., Vernon K.A., et al. This is my story: a descriptive analysis of a peer education HIV/STD risk reduction program for women living in housing developments. AIDS Educ Prev. 11:1999;43-61.
25. Kelly J.A., Murphy D.A., Sikkema K.J., et al. Randomised, controlled, community-level HIV-prevention intervention for sexual-risk behaviour among homosexual men in US cities. Community HIV Prevention Research Collaborative. Lancet. 350:1997;1500-1505.
26. Calsyn D.A., Saxon A.J., Freeman G., Whittaker S. Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am J Public Health. 82:1992;573-575.
27. Centers for Disease Control and Prevention. HIV/AIDS among men who have sex with men and inject drugs - United States, 1985-1998. MMWR Morb Mortal Wkly Rep 2000; 49: 465-70.
28. Kegeles S.M., Hays R.B., Coates T.J. The Mpowerment Project: a community HIV prevention intervention for young gay men. Am J Public Health. 86:1996;1129-1136.
29. Edlin B.R., Irwin K.L., Faruque S., et al. Intersecting epidemics - crack cocaine use and HIVinfection among inner-city young adults. N Engl J Med. 331:1994;1422-1427.
30. Astemborski J., Vlahov D., Warren D., Solomon L., Nelson K.E. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health. 84:1994;382-387.
31. Elifson K.W., Boles J., Darrow W.W., Sterk C.E. HIV seroprevalence and risk factors among clients of female and male prostitutes. J Acquir Immune Defic Syndr Hum Retrovirol. 20:1999;195-200.
32. Kral A.H., Lorvick J., Edlin B.R. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr Hum Retrovirol. 24:2000;162-167.
33. Normand J., Vlahov D., Moses L.E. Preventing HIV transmission: the role of sterile needles and bleach. 1995;National Academy Press, Washington, DC.
34. National Institutes of Health. Interventions to prevent HIVrisk behaviors. NIH Consensus Statement 1997; 15: 1-41.
35. Lurie P., Reingold A.L., Bowser B., et al. The public health impact of needle exchange programs in the United States and abroad. 1993;University of California, San Francisco.
36. Kral A.H., Bluthenthal R.N., Lorvick J., Bacchetti P., Gee L., Edlin B.R. Effect of syringe exchange utilization on a cohort of syringe sharing IDUs in San Francisco, 1989-1998. 127th meeting of the American Public Health Association 1999, Chicago, IL.
37. Watters J.K., Estilo M.J., Clark G.L., Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. J Am Med Assoc. 271:1994;115-120.
38. Bluthenthal R.N., Kral A.H., Gee L., Erringer E.A., Edlin B.R. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 14:2000;607-611.
39. Paone D., Caloir S., Shi Q., Des Jarlais D.C. Sex, drugs, and syringe exchange in New York City: women's experience. J Am Med Wom Assoc. 50:1995;109-114.
40. Weatherby N., Needle R., Cesari H., et al. Validity of self-reported drug use among injection drug users recruited through street outreach. Eval Prog Plan. 17:1994;347-355.